Pulmotect
PrivateLast Round
Series C
Sep 17, 2024
Total Funding Raised
$45.88M
Company Overview
Pulmotect is a biotechnology company developing PUL-042, a clinical-stage, inhaled therapeutic that stimulates the innate immune system to provide broad-spectrum protection against respiratory infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pulmotect Comparables
Compare Pulmotect with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ENA Respiratory | 83% | |
| NorthLinks Bio | 78% | |
| Synairgen plc | 73% | |
Pulmotect Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 17, 2024 | ||||
| Seed Round | Jan 16, 2024 | ||||
| Grant | May 30, 2023 | ||||
| Grant | Jan 27, 2021 | ||||
| Series B | Apr 4, 2018 | ||||
Series A | Apr 5, 2016 |
Pulmotect Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fannin Innovation Studio | Series A, Series C, Series B |
| Jefferson River Capital | Series B |
| U.S. Department of War | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| Axil Capital | Series C |
| Aquinas Companies, LLC | Series B |
| Cancer Prevention and Research Institute of Texas | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 17, 2024
$6M round led by Fannin Innovation Studio.
- Jan 16, 2024
Raised $3.66M in a Seed Round.
Pulmotect Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pulmotect's valuation, stock price, and market status.